Latest Regulatory Delays News

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.

Pilot Energy has secured crucial environmental approval to conduct a 3D seismic survey offshore Perth Basin, propelling its exploration and farmout ambitions forward while supporting carbon storage initiatives.

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Talga Group and SQM have mutually terminated their joint venture for the Aero Project in Sweden due to regulatory delays, with Talga now exploring new partnership opportunities to advance the critical minerals project.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

St Barbara Limited forecasts a 21% increase in gold production for FY26 at its Simberi Operations, with costs expected between A$4,000 and A$4,400 per ounce. However, key capital investment decisions hinge on unresolved Papua New Guinea tax assessments and mining lease approvals.

Elanor Investors Group has obtained a crucial ASX waiver allowing a longer timeframe to issue securities tied to its $125 million recapitalisation with Rockworth Investment. This move addresses regulatory delays and aims to stabilise Elanor's balance sheet and reduce gearing.

Locksley Resources reports robust metallurgical testwork from its Mojave Project, confirming high antimony recoveries and concentrate grades that support a domestic US supply chain. The results align with US strategic priorities for critical mineral independence.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

Aguia Resources has updated its economic study for the Tres Estrades Rock Phosphate Project, reflecting a significant uplift in phosphate pricing and expanded production capacity that together enhance the project's financial outlook.